skip to content
Home

Centre for Misfolding Diseases

Dr Maria Vias Lopez

MPACC Laboratory Manager

Publications

Omentum-derived matrix enables the study of metastatic ovarian cancer and stromal cell functions in a physiologically relevant environment
LJ Neilson, D Cartwright, M Risteli, EM Jokinen, L McGarry, T Sandvik, K Nikolatou, K Hodge, S Atkinson, M Vias, EJ Kay, JD Brenton, LM Carlin, DM Bryant, T Salo, S Zanivan
– Matrix Biol Plus
(2023)
19-20,
100136
(doi: 10.1016/j.mbplus.2023.100136)
High-grade serous ovarian carcinoma organoids as models of chromosomal instability
M Vias, L Morrill Gavarró, CM Sauer, DA Sanders, AM Piskorz, D-L Couturier, S Ballereau, B Hernando, MP Schneider, J Hall, F Correia-Martins, F Markowetz, G Macintyre, JD Brenton
– eLife
(2023)
12,
e83867
(doi: 10.7554/eLife.83867)
High-grade serous ovarian carcinoma organoids as models of chromosomal instability
M Vias, L Morrill Gavarró, C Sauer, D Sanders, A Piskorz, D-L Couturier, S Ballereau, B Hernando, J Hall, F Correia-Martins, F Markowetz, G Macintyre, J Brenton
(2022)
(doi: 10.1101/2022.09.01.506155)
Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models
CM Sauer, K Heider, J Belic, SE Boyle, JA Hall, D-L Couturier, A An, A Vijayaraghavan, MA Reinius, K Hosking, M Vias, N Rosenfeld, JD Brenton
– EMBO Molecular Medicine
(2022)
14,
e15729
(doi: 10.15252/emmm.202215729)
Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models
C Sauer, K Heider, J Belic, S Boyle, J Hall, D-L Couturier, A An, A Vijayaraghavan, MAV Reinius, K Hosking, M Vias, N Rosenfeld, J Brenton
(2022)
2022.01.15.476442
(doi: 10.1101/2022.01.15.476442)
Spatially-segmented single-cell transcriptomics by diffusional accessibility to a small-molecule dye
DB Morse, M Ceribelli, J De Jonghe, A Michalowski, C Muus, M Vias, S Boyle, DA Weitz, J Brenton, JD Buenrostro, C Thomas, TP Knowles
– Cancer Research
(2020)
80,
5879
(doi: 10.1158/1538-7445.AM2020-5879)
Combination of mTOR inhibition and paclitaxel as a personalised strategy in the context of MYC-amplified high-grade serous ovarian cancer
FC Martins, D-L Couturier, I de Santiago, M Vias, D Sanders, A Piskorz, J Hall, M Jimenez-Linan, K Hosking, R Crawford, J Brenton
– Annals of Oncology
(2019)
30,
vii10
(doi: 10.1093/annonc/mdz413.038)
No cell left behind: Residual ovarian spheroids drive recurrence and are sensitive to the pro-oxidant elesclomol
I Goldlust, K Wilson, L Szabova, X Zhang, L Mathews-Griner, M Vias, A Piskorz, R Stark, L Mendil, M Kasbekar, J Braisted, R Guha, C McKnight, P Shinn, D Michelle-Smith, ZW Ohler, M Davis, U Rudloff, S Michael, M Lal-Nag, S Martin, C Annunziata, M Ferrer, JD Brenton, C Thomas
– Cancer Research
(2016)
76,
278
(doi: 10.1158/1538-7445.AM2016-278)
Centrosomes - The Achilles' heel of high-grade serous ovarian cancer?
G Chandrasekaran, D Hall, M Vias, JD Brenton, F Gergely
– MOLECULAR BIOLOGY OF THE CELL
(2015)
26,
(link to publication)
Guidelines for the use of cell lines in biomedical research
RJ Geraghty, A Capes-Davis, JM Davis, J Downward, RI Freshney, I Knezevic, R Lovell-Badge, JRW Masters, J Meredith, GN Stacey, P Thraves, M Vias
– British Journal of Cancer
(2014)
111,
1021
(doi: 10.1038/bjc.2014.166)
  • 1 of 3
  • >

Support staff

Telephone number

01223 760880

Email address

College

Clare College

    Study at Cambridge

    About the University

    Research at Cambridge